60
u-100 insulin syringes
Worth a lookShows low returns (0.3%), but a failed launch gate (market size, growth, or returns) keeps it on the watch list.
Returns
Incredible0.3%return rate — above 6% kills the launch gate
Conversion
Incredible13.3%search→purchase rate — share of searches ending in a sale
Avg price
Great$16.70avg listing price — sweet spot $15–$100
Review moat
Good975.41avg incumbent reviews — the moat a new listing must climb
Market size
Good$489K$489K/yr · 219K searches
Price range
Good$6.16–$27.87cheapest to priciest tracked listing — scored on the share inside $15–$100
Growth
Good+31.8%90-day search growth — must beat 0% to launch
Brand share
Okay79%top-5 brand share — brands hold most of the demand
Quality gap
Okay4.5★avg incumbent rating — lower means beatable quality
Competition
Okay65%top-5 click share — leaders hold, buyers still browse